Abstract
The ligand-gated ion channels and seven transmembrane domain receptors are the greatest families of transmembrane receptors (TMR) expressed in mammalians and the major target of current available drugs. Recently, boron containing compounds (BCC) have shown capability of acting as ligands on these targets. This mini-review is focused on the description of BCC that target TMR which were evaluated under experimental models. The results in experimental models are related with the theoretical interaction studies of these ligands on the target proteins as 3D-models in order to explore the biological effects of BCC in molecular detail.
Keywords: Boron containing compound, 7TM receptor, channel receptor, drug development, synthesis, molecular recognition, ligand-gated, transmembrane, TMR, BCC, experimental models
Mini-Reviews in Medicinal Chemistry
Title: Give Boron a Chance: Boron Containing Compounds Reach Ionotropic and Metabotropic Transmembrane Receptors
Volume: 11 Issue: 12
Author(s): M. A. Soriano-Ursua, T. Mancilla-Percino, J. Correa-Basurto, E. Querejeta and J. G. Trujillo-Ferrara
Affiliation:
Keywords: Boron containing compound, 7TM receptor, channel receptor, drug development, synthesis, molecular recognition, ligand-gated, transmembrane, TMR, BCC, experimental models
Abstract: The ligand-gated ion channels and seven transmembrane domain receptors are the greatest families of transmembrane receptors (TMR) expressed in mammalians and the major target of current available drugs. Recently, boron containing compounds (BCC) have shown capability of acting as ligands on these targets. This mini-review is focused on the description of BCC that target TMR which were evaluated under experimental models. The results in experimental models are related with the theoretical interaction studies of these ligands on the target proteins as 3D-models in order to explore the biological effects of BCC in molecular detail.
Export Options
About this article
Cite this article as:
A. Soriano-Ursua M., Mancilla-Percino T., Correa-Basurto J., Querejeta E. and G. Trujillo-Ferrara J., Give Boron a Chance: Boron Containing Compounds Reach Ionotropic and Metabotropic Transmembrane Receptors, Mini-Reviews in Medicinal Chemistry 2011; 11 (12) . https://dx.doi.org/10.2174/138955711797247743
DOI https://dx.doi.org/10.2174/138955711797247743 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Current Drug Targets An Overview of Dietary Supplements on Obesity and Type 2 Diabetes: Efficacy and Mechanisms
Current Drug Metabolism Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy
Current Cancer Therapy Reviews Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes
Current Drug Targets Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Diagnosis and Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Current Drug Targets Development of Arene Ruthenium Antitumor Complexes
Mini-Reviews in Medicinal Chemistry Evaluation of the Diagnostic Properties of Serum hsa-miR-223-5p in the Detection of Gastric Cancer: A Case-Control Study
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry Non-steroidal Anti-Inflammatory Drugs and Melanoma
Current Pharmaceutical Design Phytochemicals to Prevent Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment
Current Cancer Drug Targets Epigenetic Therapies of Cancer
Current Cancer Therapy Reviews Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development
Current Drug Targets The Pim Kinases: New Targets for Drug Development
Current Drug Targets